SCHEMBL31662794

SCHEMBL31662794

Cc1cc(N2CCN(C(=O)OC(C)(C)C)CC2)ccc1CN

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.53
LMNA P02545 3/20 0.53
ALDH1A1 P00352 1/20 0.53
GPR119 Q8TDV5 8/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
CYP2C19 P33261 1/20 0.50
PDK2 Q15119 1/20 0.49
HTT P42858 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TSHR P16473 1/20 0.47
NAMPT P43490 1/20 0.47
MAPK1 P28482 1/20 0.46
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22957459 0.91 MAPT (0.51) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL27457914 0.85 MAPT (0.56) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL19212262 0.85 MAPT (0.50) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL29707320 0.85 MAPT (0.50) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL25447362 0.84 MAPT (0.60) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL214913 0.84 MAPT (0.60) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL29803690 0.84 MAPT (0.60) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL16695925 0.82 MAPT (0.57) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL470199 0.81 MAPT (0.56) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL31130014 0.81 MAPT (0.56) MAPTLMNAALDH1A1GPR119SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025147756-A1 VIRAL SENSITIZERS COMPOSITIONS, METHODS AND USES THEREOF OTTAWA HOSPITAL RESEARCH INSTITUTE (CA) 2025-07-17 WO disclosed